The cell therapy landscape is rapidly evolving, driven by technological advancements, a surge in late-stage programs, and increasing cost pressures. As therapies become more complex and regulatory demands rise, there is an urgent need for refined process development strategies to accelerate the delivery of consistent, cost-effective therapies to patients.

Join the 4th Process Development for Cell Therapies Summit to hear from 24+ industry leaders from biopharma and service providers as they share best practices for driving process robustness, scalability, speed, and affordability. Gain insights into how to develop consistent, scalable, and cost-effective solutions for both autologous and allogeneic cell therapies.

Engage with 70+ process development specialists and professionals from MSAT, QC, and CMC to address the most pressing PD bottlenecks and streamline the transition from early to late-stage development. Gain technical and strategic insights to enhance scalability and ensure regulatory readiness, helping you position your therapy for long-term commercial success.

Explore the latest innovations from Galapagos, Takeda, Cellectis, and Arsenal Bio as they share real-world case studies on transformative tools and technologies, including automated closed-system manufacturing, workflow digitization, and artificial intelligence.

Event link here.